In committee
To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.
People affected—not yet estimated
Fiscal magnitude—not yet estimated
Reach—
How your members of Congress line up
How it moved.
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
- Introduced in House